RhumbLine Advisers’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Buy
481,250
+284,194
+144% +$2.2M ﹤0.01% 1448
2026
Q1
$1.26M Buy
197,056
+6,930
+4% +$48.2K ﹤0.01% 2082
2025
Q4
$1.34M Sell
190,126
-8,544
-4% -$51.6K ﹤0.01% 2075
2025
Q3
$1.09M Sell
198,670
-5,343
-3% -$26.2K ﹤0.01% 2199
2025
Q2
$1.05M Buy
204,013
+8,267
+4% +$49.5K ﹤0.01% 2214
2025
Q1
$1.3M Buy
195,746
+165
+0.1% +$1.25K ﹤0.01% 2046
2024
Q4
$1.44M Buy
195,581
+8,487
+5% +$60.9K ﹤0.01% 2063
2024
Q3
$1.31M Buy
187,094
+4,963
+3% +$29.8K ﹤0.01% 2120
2024
Q2
$894K Buy
182,131
+27,280
+18% +$164K ﹤0.01% 2306
2024
Q1
$955K Buy
154,851
+2,379
+2% +$16K ﹤0.01% 2277
2023
Q4
$1.19M Sell
152,472
-2,597
-2% -$16.7K ﹤0.01% 2163
2023
Q3
$1.07M Buy
155,069
+8,905
+6% +$72.2K ﹤0.01% 2169
2023
Q2
$1.33M Buy
146,164
+30,933
+27% +$257K ﹤0.01% 2145
2023
Q1
$856K Buy
115,231
+4,249
+4% +$23.6K ﹤0.01% 2197
2022
Q4
$548K Buy
110,982
+1,417
+1% +$8.76K ﹤0.01% 2422
2022
Q3
$725K Buy
109,565
+6,076
+6% +$42.4K ﹤0.01% 2318
2022
Q2
$575K Buy
103,489
+30,746
+42% +$235K ﹤0.01% 2422
2022
Q1
$735K Buy
72,743
+24,252
+50% +$213K ﹤0.01% 2257
2021
Q4
$462K Buy
48,491
+472
+1% +$5K ﹤0.01% 2541
2021
Q3
$696K Buy
+48,019
New +$925K ﹤0.01% 2398

Other funds holding LFST

RhumbLine Advisers's LFST Position: Q2 2026 in Review

RhumbLine Advisers increased its Lifestance Health (LFST) stake by 144% in Q2 2026, buying an estimated $2.2M and bringing the position to 481,250 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

RhumbLine Advisers first reported a position in LFST in Q3 2021 and has held it in 20 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • RhumbLine Advisers held 481,250 shares of Lifestance Health worth $5.15M as of Q2 2026.
  • RhumbLine Advisers bought 284,194 Lifestance Health shares in Q2 2026, an estimated $2.2M.
  • Lifestance Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1448 holding.
  • RhumbLine Advisers first reported a position in Lifestance Health in Q3 2021 and has held it in 20 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.